223 related articles for article (PubMed ID: 22453175)
21. Regulation of proteasomes in prion disease.
Zhu T; Hayat Khan S; Zhao D; Yang L
Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):531-9. PubMed ID: 24829398
[TBL] [Abstract][Full Text] [Related]
22. Disease-related prion protein forms aggresomes in neuronal cells leading to caspase activation and apoptosis.
Kristiansen M; Messenger MJ; Klöhn PC; Brandner S; Wadsworth JD; Collinge J; Tabrizi SJ
J Biol Chem; 2005 Nov; 280(46):38851-61. PubMed ID: 16157591
[TBL] [Abstract][Full Text] [Related]
23. Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.
Meneghetti E; Gasperini L; Virgilio T; Moda F; Tagliavini F; Benetti F; Legname G
Mol Neurobiol; 2019 Sep; 56(9):6035-6045. PubMed ID: 30710214
[TBL] [Abstract][Full Text] [Related]
24. A hypothesis on prion disorders: are infectious, inherited, and sporadic causes so distinct?
Fornai F; Ferrucci M; Gesi M; Bandettini di Poggio A; Giorgi FS; Biagioni F; Paparelli A
Brain Res Bull; 2006 Mar; 69(2):95-100. PubMed ID: 16533656
[TBL] [Abstract][Full Text] [Related]
25. Protein misfolding cyclic amplification (PMCA): Current status and future directions.
Saá P; Cervenakova L
Virus Res; 2015 Sep; 207():47-61. PubMed ID: 25445341
[TBL] [Abstract][Full Text] [Related]
26. Prion protein oligomer and its neurotoxicity.
Huang P; Lian F; Wen Y; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):442-51. PubMed ID: 23557632
[TBL] [Abstract][Full Text] [Related]
27. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
Ciechanover A; Kwon YT
Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
[TBL] [Abstract][Full Text] [Related]
28. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
29. Rapid cell-surface prion protein conversion revealed using a novel cell system.
Goold R; Rabbanian S; Sutton L; Andre R; Arora P; Moonga J; Clarke AR; Schiavo G; Jat P; Collinge J; Tabrizi SJ
Nat Commun; 2011; 2():281. PubMed ID: 21505437
[TBL] [Abstract][Full Text] [Related]
30. Proteasome inhibitors promote the sequestration of PrPSc into aggresomes within the cytosol of prion-infected CAD neuronal cells.
Dron M; Dandoy-Dron F; Farooq Salamat MK; Laude H
J Gen Virol; 2009 Aug; 90(Pt 8):2050-2060. PubMed ID: 19339478
[TBL] [Abstract][Full Text] [Related]
31. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
[TBL] [Abstract][Full Text] [Related]
32. Prion protein self-interactions: a gateway to novel therapeutic strategies?
Rigter A; Langeveld JP; van Zijderveld FG; Bossers A
Vaccine; 2010 Nov; 28(49):7810-23. PubMed ID: 20932496
[TBL] [Abstract][Full Text] [Related]
33. Prion degradation pathways: Potential for therapeutic intervention.
Goold R; McKinnon C; Tabrizi SJ
Mol Cell Neurosci; 2015 May; 66(Pt A):12-20. PubMed ID: 25584786
[TBL] [Abstract][Full Text] [Related]
34. Cellular aspects of prion replication in vitro.
Grassmann A; Wolf H; Hofmann J; Graham J; Vorberg I
Viruses; 2013 Jan; 5(1):374-405. PubMed ID: 23340381
[TBL] [Abstract][Full Text] [Related]
35. Prion diseases and their biochemical mechanisms.
Cobb NJ; Surewicz WK
Biochemistry; 2009 Mar; 48(12):2574-85. PubMed ID: 19239250
[TBL] [Abstract][Full Text] [Related]
36. New insights into prion structure and toxicity.
Harris DA; True HL
Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
[TBL] [Abstract][Full Text] [Related]
37. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
[TBL] [Abstract][Full Text] [Related]
38. Structural factors underlying the species barrier and susceptibility to infection in prion disease.
Sweeting B; Khan MQ; Chakrabartty A; Pai EF
Biochem Cell Biol; 2010 Apr; 88(2):195-202. PubMed ID: 20453922
[TBL] [Abstract][Full Text] [Related]
39. beta-sheet constitution of prion proteins.
Ji HF; Zhang HY
Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302
[TBL] [Abstract][Full Text] [Related]
40. Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol.
Wang X; Wang F; Sy MS; Ma J
J Biol Chem; 2005 Jan; 280(1):317-25. PubMed ID: 15525638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]